BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23617347)

  • 1. Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNS.
    Papadatos-Pastos D; Januszewski A; Dalgleish A
    Expert Rev Anticancer Ther; 2013 May; 13(5):559-67. PubMed ID: 23617347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: opportunities and unanswered questions.
    Murrell J; Board R
    Cancer Treat Rev; 2013 Dec; 39(8):833-8. PubMed ID: 23845462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic brain metastases in patients with cutaneous metastatic malignant melanoma.
    Zukauskaite R; Schmidt H; Asmussen JT; Hansen O; Bastholt L
    Melanoma Res; 2013 Feb; 23(1):21-6. PubMed ID: 23117880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of melanoma brain metastases: a new paradigm.
    Carlino MS; Fogarty GB; Long GV
    Cancer J; 2012; 18(2):208-12. PubMed ID: 22453023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic strategies and systemic treatment of brain melanoma metastases].
    Durando X; Mansard S; Daste A; Gimbergues P; Brocard L; Magné N; Thivat E
    Bull Cancer; 2013 Jan; 100(1):23-8. PubMed ID: 22889847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.
    Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK
    Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in therapy for melanoma brain metastases.
    Flanigan JC; Jilaveanu LB; Chiang VL; Kluger HM
    Clin Dermatol; 2013; 31(3):264-81. PubMed ID: 23608446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fotemustine in the treatment of brain primary tumors and metastases.
    Khayat D; Giroux B; Berille J; Cour V; Gerard B; Sarkany M; Bertrand P; Bizzari JP
    Cancer Invest; 1994; 12(4):414-20. PubMed ID: 8032964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival in metastatic malignant melanoma: ipilimumab followed by vemurafenib in a patient with brain metastasis.
    Balakan O; Süner A; Yiğiter R; Balakan T; Sirikçi A; Sevinç A
    Intern Med; 2012; 51(19):2819-23. PubMed ID: 23037483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
    Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
    Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma in the brain: biology and therapeutic options.
    Gibney GT; Forsyth PA; Sondak VK
    Melanoma Res; 2012 Jun; 22(3):177-83. PubMed ID: 22495668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNS metastasis: an old problem in a new guise.
    Aragon-Ching JB; Zujewski JA
    Clin Cancer Res; 2007 Mar; 13(6):1644-7. PubMed ID: 17363516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of melanoma brain metastases.
    Goldinger SM; Panje C; Nathan P
    Curr Opin Oncol; 2016 Mar; 28(2):159-65. PubMed ID: 26809015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
    Avril MF; Aamdal S; Grob JJ; Hauschild A; Mohr P; Bonerandi JJ; Weichenthal M; Neuber K; Bieber T; Gilde K; Guillem Porta V; Fra J; Bonneterre J; Saïag P; Kamanabrou D; Pehamberger H; Sufliarsky J; Gonzalez Larriba JL; Scherrer A; Menu Y
    J Clin Oncol; 2004 Mar; 22(6):1118-25. PubMed ID: 15020614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality management of brain metastases in metastatic melanoma patients.
    Samlowski WE; Jensen RL; Shrieve DC
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1699-705. PubMed ID: 18062744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of brain metastases in melanoma patients.
    Bafaloukos D; Gogas H
    Cancer Treat Rev; 2004 Oct; 30(6):515-20. PubMed ID: 15325032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metastases from malignant melanoma.
    Chiarion-Sileni V; Murr R; Pigozzo J; Sarti S; Tomassi O; Romanini A
    Forum (Genova); 2003; 13(2):170-82; quiz 190. PubMed ID: 14732883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of thalidomide in patients with brain metastases from malignant melanoma.
    Vestermark LW; Larsen S; Lindeløv B; Bastholt L
    Acta Oncol; 2008; 47(8):1526-30. PubMed ID: 18607876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain metastases in breast cancer: prognostic factors and management.
    Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
    Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.